282 related articles for article (PubMed ID: 24369411)
1. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.
Weber-Schoendorfer C; Hoeltzenbein M; Wacker E; Meister R; Schaefer C
Rheumatology (Oxford); 2014 Apr; 53(4):757-63. PubMed ID: 24369411
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
Weber-Schoendorfer C; Chambers C; Wacker E; Beghin D; Bernard N; ; Shechtman S; Johnson D; Cuppers-Maarschalkerweerd B; Pistelli A; Clementi M; Winterfeld U; Eleftheriou G; Pupco A; Kao K; Malm H; Elefant E; Koren G; Vial T; Ornoy A; Meister R; Schaefer C
Arthritis Rheumatol; 2014 May; 66(5):1101-10. PubMed ID: 24470106
[TBL] [Abstract][Full Text] [Related]
3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
4. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
Viktil KK; Engeland A; Furu K
Scand J Rheumatol; 2012 May; 41(3):196-201. PubMed ID: 22401133
[TBL] [Abstract][Full Text] [Related]
5. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
[TBL] [Abstract][Full Text] [Related]
6. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature.
Ostensen M; Hartmann H; Salvesen K
J Rheumatol; 2000 Aug; 27(8):1872-5. PubMed ID: 10955326
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate embryopathy after exposure to low weekly doses in early pregnancy.
Martín MC; Barbero P; Groisman B; Aguirre MÁ; Koren G
Reprod Toxicol; 2014 Jan; 43():26-9. PubMed ID: 24513926
[TBL] [Abstract][Full Text] [Related]
8. The toxicity of methotrexate in male fertility and paternal teratogenicity.
Gutierrez JC; Hwang K
Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):51-58. PubMed ID: 27590039
[TBL] [Abstract][Full Text] [Related]
9. Birth outcomes after preconception paternal exposure to methotrexate: A nationwide cohort study.
Winter RW; Larsen MD; Magnussen B; Friedman S; Kammerlander H; Nørgård BM
Reprod Toxicol; 2017 Dec; 74():219-223. PubMed ID: 29080667
[TBL] [Abstract][Full Text] [Related]
10. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding).
Martínez Lopez JA; Loza E; Carmona L
Clin Exp Rheumatol; 2009; 27(4):678-84. PubMed ID: 19772806
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
[TBL] [Abstract][Full Text] [Related]
12. [Pregnancy outcome after preconceptional exposure to methotrexate for ectopic pregnancy].
Lagarce L; Bernard N; Carlier P; Phelipot-Lates S; Perault-Pochat MC; Drablier G; Bourneau-Martin D; Lainé-Cessac P;
Therapie; 2016 Sep; 71(4):389-94. PubMed ID: 27203166
[TBL] [Abstract][Full Text] [Related]
13. The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy.
Svirsky R; Rozovski U; Vaknin Z; Pansky M; Schneider D; Halperin R
Reprod Toxicol; 2009 Jan; 27(1):85-7. PubMed ID: 19103279
[TBL] [Abstract][Full Text] [Related]
14. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
Chakravarty EF; Sanchez-Yamamoto D; Bush TM
J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
[TBL] [Abstract][Full Text] [Related]
15. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease.
Kozlowski RD; Steinbrunner JV; MacKenzie AH; Clough JD; Wilke WS; Segal AM
Am J Med; 1990 Jun; 88(6):589-92. PubMed ID: 2189302
[TBL] [Abstract][Full Text] [Related]
16. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
[TBL] [Abstract][Full Text] [Related]
17. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy course and outcome after intracytoplasmic sperm injection: a controlled, prospective cohort study.
Katalinic A; Rösch C; Ludwig M;
Fertil Steril; 2004 Jun; 81(6):1604-16. PubMed ID: 15193484
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine.
Hoeltzenbein M; Weber-Schoendorfer C; Borisch C; Allignol A; Meister R; Schaefer C
Reprod Toxicol; 2012 Nov; 34(3):364-9. PubMed ID: 22609326
[TBL] [Abstract][Full Text] [Related]
20. Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic.
Nurmohamed L; Moretti ME; Schechter T; Einarson A; Johnson D; Lavigne SV; Erebara A; Koren G; Finkelstein Y
Am J Obstet Gynecol; 2011 Dec; 205(6):533.e1-3. PubMed ID: 21907957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
